Total Funding
88
61
Total FundingGrant raised
Growth Score
-6 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
50535
AI4Eyes uses AI to enhance the diagnosis and treatment of dry eye disease, aiding healthcare professionals in ophthalmology.
- Daniel Hofman: Co-founder & Chairman of the BoardPast Role: I-MED Pharma, Territory Manager
- Henry Reis: CEO & Co-Founder
About the Company
AI4Eyes focuses on leveraging artificial intelligence to improve the diagnosis and treatment of dry eye disease. The company provides tools and solutions that assist healthcare professionals in identifying and managing this condition more effectively. By utilizing machine learning algorithms, AI4Eyes aims to enhance clinical decision-making and
patient outcomes in ophthalmology. The company addresses the complexity of dry eye disease and the challenges faced by doctors in staying updated with the latest practices.
